1-[n-(naphthalen-2-ylsulfonyl)glycyl-4-carbamimidoyl-d-phenylalanyl]piperidine (MID) Summary

Clusters summary
Clustering method gromos
Clustering metric RSMdi
Initial clustering cutoff (nm) 0.05
Final clustering cutoff (nm) 0.15
Number of clusters 28
Number of clusters representing 95% 9
Cluster Population
Clusters Convergence
ΔG WITH RESPECT TO BIOACTIVE CONFORMATION
ΔGdist (kcal/mol) 1.3179
ΔGstrain (kcal/mol) 0.4882
Conformations Table
ClNum ClPop ΔG Cl-Cl RMSd Exp
1 2463 0 2.8362
2 1430 0.3219 3.8471
3 1425 0.3240 3.9273
4 1264 0.3950 3.6504
5 1080 0.4882 1.6332
6 710 0.7366 3.5902
7 594 0.8422 4.4129
8 486 0.9610 2.8148
9 379 1.1083 2.2421
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)